Floatz logo

231 assets in Endometrial Carcinoma

Therapeutic assets addressing Endometrial Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Pan-Fgfr Tyrosine Kinase Inhibitor Jnj-42756493
Endometrial Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Panitumumab
Endometrial Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Relatlimab
Endometrial Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Selumetinib
Endometrial Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Sotorasib
Endometrial Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Trametinib
Endometrial Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Trastuzumab Emtansine
Endometrial Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Ulixertinib
Endometrial Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Vismodegib
Endometrial Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Adavosertib
Endometrial Carcinoma
National Cancer Institute (NCI)P2CCC (52)
Alpelisib
Endometrial Carcinoma
National Cancer Institute (NCI)P2CCC (52)
Anastrozole
Endometrial Carcinoma
Jonsson Comprehensive Cancer CenterP2CCC (52)
Canagliflozin
Endometrial Carcinoma
Faeth TherapeuticsP2CCC (52)
Capecitabine
Endometrial Carcinoma
AstraZenecaP2CCC (52)
Datopotamab Deruxtecan
Endometrial Carcinoma
AstraZenecaP2CCC (52)
Everolimus
Endometrial Carcinoma
Eli Lilly and CompanyP2CCC (52)
Immunoglobulin G2, Anti-(Human Ctla-4 (Antigen)) (Human Monoclonal Cp-675206 Clone 11.2.1 Heavy Chain) Disulphide With Human Monoclonal Cp-675206 Clone 11.2.1 Light Chain, Dimer
Endometrial Carcinoma
Vall d'Hebron Institute of OncologyP2CCC (52)
Levonorgestrel
Endometrial Carcinoma
Washington University School of MedicineP2CCC (52)
Pertuzumab
Endometrial Carcinoma
Eli Lilly and CompanyP2CCC (52)
Tirzepatide
Endometrial Carcinoma
UNC Lineberger Comprehensive Cancer CenterP2CCC (52)
Tpst-1495
Endometrial Carcinoma
University of OklahomaP2CCC (52)
Favezelimab
Endometrial Carcinoma
Merck Sharp & Dohme LLCP2CCC (51)
Serabelisib
Endometrial Carcinoma
Faeth TherapeuticsP2CCC (51)
Taselisib
Endometrial Carcinoma
National Cancer Institute (NCI)P2CCC (51)
[18f]f-resca-rt4
Endometrial Carcinoma
RenJi HospitalP2/3CCC (50)
[18F]F-RESCA-T4
Endometrial Carcinoma
RenJi HospitalP2/3CCC (50)
[68ga]ga-nota-rt4
Endometrial Carcinoma
RenJi HospitalP2/3CCC (50)
[68ga]ga-nota-t4
Endometrial Carcinoma
RenJi HospitalP2/3CCC (50)
Diphenoxylate
Endometrial Carcinoma
National Cancer Institute (NCI)P2CCC (50)
Gedatolisib
Endometrial Carcinoma
Dana-Farber Cancer InstituteP2CCC (49)
Belzutifan
Endometrial Carcinoma
Dana-Farber Cancer InstituteP2CCC (48)
Copanlisib
Endometrial Carcinoma
M.D. Anderson Cancer CenterP2CCC (48)
Fog-001
Endometrial Carcinoma
Parabilis Medicines, Inc.P1/2CCC (48)
her3-dxd
Endometrial Carcinoma
Daiichi SankyoP2CCC (48)
hs-20089
Endometrial Carcinoma
Hansoh BioMedical R&D CompanyP2CCC (48)
Lorigerlimab
Endometrial Carcinoma
MacroGenicsP2CCC (48)
ly3023414
Endometrial Carcinoma
Dana-Farber Cancer InstituteP2CCC (48)
Mdna11
Endometrial Carcinoma
Medicenna Therapeutics, Inc.P1/2CCC (48)
Prednisolone
Endometrial Carcinoma
AstraZenecaP2CCC (48)
Prednisone
Endometrial Carcinoma
AstraZenecaP2CCC (48)
(R)-(1-(4-Fluorophenyl)-6-((1-Methyl-1H-Pyrazol-4-Yl)Sulfonyl)-1,4,5,6,7,8-Hexahydro-4Ah-Pyrazolo(3,4-G)Isoquinolin-4A-Yl)(4-(Trifluoromethyl)Pyridin-2-Yl)Methanone
Endometrial Carcinoma
Corcept TherapeuticsP2CCC (48)
Sapanisertib
Endometrial Carcinoma
Faeth TherapeuticsP2CCC (48)
Tegavivint
Endometrial Carcinoma
Children's Oncology GroupP1/2CCC (48)
Tipiracil
Endometrial Carcinoma
Parabilis Medicines, Inc.P1/2CCC (48)
Trifluridine
Endometrial Carcinoma
Parabilis Medicines, Inc.P1/2CCC (48)
Trilaciclib
Endometrial Carcinoma
Sun Yat-sen UniversityP2CCC (48)
Volrustomig
Endometrial Carcinoma
AstraZenecaP2CCC (48)
Zanidatamab
Endometrial Carcinoma
Jazz PharmaceuticalsP2CCC (48)
Dordaviprone
Endometrial Carcinoma
UNC Lineberger Comprehensive Cancer CenterP2CC (47)
Ribociclib
Endometrial Carcinoma
Avenzo Therapeutics, Inc.P1/2CC (46)
Showing 51 to 100 of 231 assets
PreviousPage 2 of 5Next